Select Publications
Journal articles
2013, 'Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN', Cell Metabolism, 17, pp. 236 - 248, http://dx.doi.org/10.1016/j.cmet.2013.01.006
,2013, 'Corrigendum to "Neuropeptide Y is important for basal and seizure-induced precursor cell proliferation in the hippocampus" [Neurobiol. Dis. 26/1 (2007) 174-188]', Neurobiology of Disease, 49, pp. 199, http://dx.doi.org/10.1016/j.nbd.2012.06.006
,2013, 'Intermittent energy restriction improves fat loss efficiency in diet-induced obese mice', Obesity Research & Clinical Practice, 7, pp. e25 - e25, http://dx.doi.org/10.1016/j.orcp.2013.12.550
,2013, 'Knockdown of prodynorphin gene prevents cognitive decline, reduces anxiety, and rescues loss of group 1 metabotropic glutamate receptor function in aging', Journal of Neuroscience, 33, pp. 12792 - 12804, http://dx.doi.org/10.1523/JNEUROSCI.0290-13.2013
,2013, 'Neuropeptide FF receptor-2 signalling is critical for diet-induced thermogenesis regulation', Obesity Research & Clinical Practice, 7, pp. e28 - e29, http://dx.doi.org/10.1016/j.orcp.2013.12.556
,2013, 'Neuropeptide y is a critical modulator of Leptin's regulation of cortical bone', Journal of Bone and Mineral Research, 28, pp. 886 - 898, http://dx.doi.org/10.1002/jbmr.1786
,2013, 'Neuropeptide Y mediates the short-term hypometabolic effect of estrogen deficiency in mice', International Journal of Obesity, 37, pp. 390 - 398, http://dx.doi.org/10.1038/ijo.2012.71
,2013, 'Postprandial cardiac autonomic function in Prader-Willi syndrome', Clinical Endocrinology, 79, pp. 128 - 133, http://dx.doi.org/10.1111/cen.12084
,2012, '30 Years of NPY research', Neuropeptides, 46, pp. 251, http://dx.doi.org/10.1016/j.npep.2012.10.002
,2012, '30Years of NPY research.', Neuropeptides, 46, pp. 251
,2012, 'A mass spectrometric assay for the quantification of neuropeptide PYY in plasma', Analytical Methods, 4, pp. 714 - 720, http://dx.doi.org/10.1039/c2ay05536h
,2012, 'A role for neuropeptide y in the gender-specific gastrointestinal, corticosterone and feeding responses to stress', British Journal of Pharmacology, 166, pp. 2307 - 2316, http://dx.doi.org/10.1111/j.1476-5381.2012.01939.x
,2012, 'Critical role of Neuropeptide FF receptor 2 in the regulation of energy balance and glucose homeostasis revealed in mice', Obesity Research & Clinical Practice, 6, pp. 17 - 17, http://dx.doi.org/10.1016/j.orcp.2012.08.035
,2012, 'Distribution of Y-Receptors in Murine Lingual Epithelia', PLoS ONE, 7, pp. e46358, http://dx.doi.org/10.1371/journal.pone.0046358
,2012, 'Influence of sex and genetic background on anxiety-related and stress-induced behaviour of prodynorphin-deficient mice', PLoS ONE, 7, pp. Article number e34251, http://dx.doi.org/10.1371/journal.pone.0034251
,2012, 'Macrophage inhibitory cytokine 1 (MIC-1/GDF15) decreases food intake, body weight and improves glucose tolerance in mice on normal & obesogenic diets', PLoS One, 7, pp. e34868, http://dx.doi.org/10.1371/journal.pone.0034868
,2012, 'Neuropeptide Y and peptide YY have distinct roles in adult mouse olfactory neurogenesis', Journal of Neuroscience Research, 90, pp. 1126 - 1135, http://dx.doi.org/10.1002/jnr.23008
,2012, 'Neuropeptide Y modulates fear and fear extinction in distinct nuclei of the amygdala', BMC Pharmacology and Toxicology, 13, http://dx.doi.org/10.1186/2050-6511-13-s1-a87
,2012, 'Neuropeptide y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity', Diabetes, 61, pp. 3228 - 3238, http://dx.doi.org/10.2337/db12-0156
,2012, 'Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease', Neurobiology of Aging, 33, pp. 2125 - 2137, http://www.ncbi.nlm.nih.gov/pubmed/21816512
,2012, 'NPY controls fear conditioning and fear extinction by combined action on Y 1 and Y 2 receptors', British Journal of Pharmacology, 166, pp. 1461 - 1473, http://dx.doi.org/10.1111/j.1476-5381.2012.01872.x
,2012, 'NPY modulates PYY function in the regulation of energy balance and glucose homeostasis', Diabetes Obesity and Metabolism, 14, pp. 727 - 736, http://dx.doi.org/10.1111/j.1463-1326.2012.01592.x
,2012, 'NPY receptor subtype specification for behavioral adaptive strategies during limited food access', Genes Brain and Behavior, 11, pp. 105 - 112, http://dx.doi.org/10.1111/j.1601-183X.2011.00732.x
,2012, 'NPY: Beyond the regulation of energy metabolism', Obesity Research & Clinical Practice, 6, pp. 2 - 3, http://dx.doi.org/10.1016/j.orcp.2012.08.005
,2012, 'Peptide YY and neuropeptide Y in regulation of pain and spatial learning and memory', BMC Pharmacology and Toxicology, 13, http://dx.doi.org/10.1186/2050-6511-13-s1-a58
,2012, 'Secretoneurin, substance P and neuropeptide Y in the oxygen-induced retinopathy in C57Bl/6N mice', Peptides, 37, pp. 252 - 257, http://dx.doi.org/10.1016/j.peptides.2012.07.024
,2012, 'The role of NPY and Ghrelin in anorexia nervosa', Current Pharmaceutical Design, 18, pp. 4766 - 4778, http://www.ncbi.nlm.nih.gov/pubmed/22632858
,2011, 'Endogenous peptide YY and neuropeptide y inhibit colonic ion transport, contractility and transit differentially via Y1 and Y2 receptors', British Journal of Pharmacology, 164, pp. 471 - 484, http://dx.doi.org/10.1111/j.1476-5381.2011.01401.x
,2011, 'Hypothalamus-specific deletion of Y1 and Y5 receptors EXACERBATES high fat diet-induced obesity', Obesity Research & Clinical Practice, 5, pp. 41 - 41, http://dx.doi.org/10.1016/j.orcp.2011.08.134
,2011, 'In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels', Neuropeptides, 45, pp. 301 - 307, http://dx.doi.org/10.1016/j.npep.2011.06.001
,2011, 'Kappa opioid receptor activation blocks progressive neurodegeneration after kainic acid injection', Hippocampus, 21, pp. 1010 - 1020, http://dx.doi.org/10.1002/hipo.20813
,2011, 'Modulation of taste sensitivity and feeding by oral PYY signaling', Appetite, 57, pp. S24 - S24, http://dx.doi.org/10.1016/j.appet.2011.05.204
,2011, 'Neuropeptide Y and peptide YY: Important regulators of energy metabolism', Current Opinion in Endocrinology and Diabetes, 18, pp. 56 - 60, http://dx.doi.org/10.1097/MED.0b013e3283422f0a
,2011, 'Neuropeptide Y Y2 receptors modulate trace fear conditioning and spatial memory in the dorsal hippocampus', BMC Pharmacology, 11, http://dx.doi.org/10.1186/1471-2210-11-s2-a2
,2011, 'NPY receptors as potential targets for anti-obesity drug development', British Journal of Pharmacology, 163, pp. 1170 - 1202, http://dx.doi.org/10.1111/j.1476-5381.2011.01363.x
,2011, 'Reduced fear conditioning after viral vector mediated neuropeptide Y administration into the basolateral amygdala', BMC Pharmacology, 11, http://dx.doi.org/10.1186/1471-2210-11-s2-a3
,2011, 'Response properties of the electrosensory neurons in hindbrain of the white sturgeon, Acipenser transmontanus', Neurosci Bull, 27, pp. 422 - 429
,2011, 'Salivary PYY: A putative bypass to satiety', PLoS One, 5, pp. Article no. e26137, http://dx.doi.org/10.1371/journal.pone.0026137
,2011, 'Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide y', British Journal of Pharmacology, 163, pp. 1302 - 1314, http://dx.doi.org/10.1111/j.1476-5381.2011.01326.x
,2011, 'The neuropeptide y system: Pathophysiological and therapeutic implications in obesity and cancer', Pharmacology and Therapeutics, 131, pp. 91 - 113, http://dx.doi.org/10.1016/j.pharmthera.2011.03.011
,2011, 'Y1 signalling has a critical role in allergic airway inflammation', Immunology and Cell Biology, 89, pp. 882 - 888, http://dx.doi.org/10.1038/icb.2011.6
,2010, 'Synthesis of Neuropeptide Y analogues as PET imaging agents', JOURNAL OF PEPTIDE SCIENCE, 16, pp. 89 - 89, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000281610800213&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2010, 'Acoustic startle response and sensorimotor gating in a genetic mouse model for the NPY Y1 receptor.', Neuropeptides, 44, pp. 233 - 239
,2010, 'Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation', Diabetes Obesity and Metabolism, 12, pp. 591 - 603
,2010, 'Adult-onset hippocampal-specific neuropeptide Y overexpression confers mild anxiolytic effect in mice', European Neuropsychopharmacology, 20, pp. 164 - 175
,2010, 'Critical role for ghrelin, but not PYY or GLP-1, in Prader–Willi syndrome hyperphagia', Obesity Research & Clinical Practice, 4, pp. S6 - S6, http://dx.doi.org/10.1016/j.orcp.2010.09.013
,2010, 'Delayed stress-induced differences in locomotor and depression-related behaviour in female neuropeptide-Y Y1 receptor knockout mice', Journal of Psychopharmacology, 24, pp. 1541-9, http://dx.doi.org/10.1177/0269881109104851
,2010, 'Endogenous dynorphin in emotional control and stress response revisited', BMC Pharmacology, 10, http://dx.doi.org/10.1186/1471-2210-10-s1-a32
,2010, 'Evidence from knockout mice that neuropeptide-Y Y2 and Y4 receptor signalling prevents long-term depression-like behaviour caused by immune challenge', Journal of Psychopharmacology, 24, pp. 1551 - 1560
,2010, 'Gastrointestinal peptides and bone health', Current Opinion in Endocrinology and Diabetes, 17, pp. 44 - 50
,